Nicole Huebener

806 total citations
24 papers, 664 citations indexed

About

Nicole Huebener is a scholar working on Neurology, Molecular Biology and Immunology. According to data from OpenAlex, Nicole Huebener has authored 24 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 14 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Nicole Huebener's work include Neuroblastoma Research and Treatments (16 papers), Immunotherapy and Immune Responses (8 papers) and Virus-based gene therapy research (5 papers). Nicole Huebener is often cited by papers focused on Neuroblastoma Research and Treatments (16 papers), Immunotherapy and Immune Responses (8 papers) and Virus-based gene therapy research (5 papers). Nicole Huebener collaborates with scholars based in Germany, United States and Austria. Nicole Huebener's co-authors include Holger N. Lode, Gerhard Gaedicke, Stefan Fest, Diana Seidel, Yan Zeng, Winfried S. Wels, Silke Weixler, Anne Strandsby, Stephen D. Gillies and Kurt Schönfeld and has published in prestigious journals such as Blood, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Nicole Huebener

24 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Huebener Germany 15 334 330 248 227 156 24 664
Nourredine Himoudi United Kingdom 14 292 0.9× 351 1.1× 98 0.4× 164 0.7× 60 0.4× 18 599
Cristina Mastini Italy 13 228 0.7× 275 0.8× 45 0.2× 246 1.1× 46 0.3× 15 557
Silke Landmeier Germany 11 399 1.2× 351 1.1× 58 0.2× 83 0.4× 105 0.7× 12 545
Lisa P. Seung United States 8 205 0.6× 210 0.6× 15 0.1× 246 1.1× 202 1.3× 10 555
Qun Tao China 12 209 0.6× 293 0.9× 15 0.1× 210 0.9× 112 0.7× 26 549
Bipulendu Jena United States 8 610 1.8× 315 1.0× 21 0.1× 235 1.0× 251 1.6× 14 725
Alberto Comes Italy 12 371 1.1× 616 1.9× 22 0.1× 146 0.6× 75 0.5× 14 717
Julien Fleurence France 7 217 0.6× 140 0.4× 39 0.2× 144 0.6× 52 0.3× 9 333
R. Masood United States 8 231 0.7× 169 0.5× 24 0.1× 212 0.9× 30 0.2× 14 583
Larry D. Greenfield United States 8 83 0.2× 216 0.7× 69 0.3× 124 0.5× 29 0.2× 14 400

Countries citing papers authored by Nicole Huebener

Since Specialization
Citations

This map shows the geographic impact of Nicole Huebener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Huebener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Huebener more than expected).

Fields of papers citing papers by Nicole Huebener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Huebener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Huebener. The network helps show where Nicole Huebener may publish in the future.

Co-authorship network of co-authors of Nicole Huebener

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Huebener. A scholar is included among the top collaborators of Nicole Huebener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Huebener. Nicole Huebener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soldati, Rocío, Nicole Huebener, Oliver Höhn, et al.. (2013). Salmonella SL7207 application is the most effective DNA vaccine delivery method for successful tumor eradication in a murine model for neuroblastoma. Cancer Letters. 331(2). 167–173. 54 indexed citations
2.
Lode, Holger N., Manuela Schmidt, Diana Seidel, et al.. (2013). Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response. Cancer Immunology Immunotherapy. 62(6). 999–1010. 39 indexed citations
3.
Seidel, Diana, Srinivas S. Somanchi, Dean A. Lee, et al.. (2012). Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity. Journal of Molecular Medicine. 91(4). 459–472. 17 indexed citations
4.
Esser, Ruth, Tina Müller, Stephan Kloeß, et al.. (2011). NK cells engineered to express a GD2‐specific antigen receptor display built‐in ADCC‐like activity against tumour cells of neuroectodermal origin. Journal of Cellular and Molecular Medicine. 16(3). 569–581. 166 indexed citations
5.
Fest, Stefan, Nicole Huebener, Christiane Landgraf, et al.. (2009). Systematic amino acid substitutions improved efficiency of GD2-peptide mimotope vaccination against neuroblastoma. European Journal of Cancer. 45(16). 2915–2921. 16 indexed citations
6.
Fest, Stefan, Nicole Huebener, Tahir Durmus, et al.. (2009). Survivin minigene DNA vaccination is effective against neuroblastoma. International Journal of Cancer. 125(1). 104–114. 55 indexed citations
7.
Bernt, Kathrin M., Aram Prokop, Nicole Huebener, et al.. (2009). Eradication of CD19+ Leukemia by Targeted Calicheamicin θ. Bioconjugate Chemistry. 20(8). 1587–1594. 11 indexed citations
8.
Huebener, Nicole, et al.. (2008). A novel legumain DNA vaccine effectively eradicates neuroblastoma and induces long-term survival in vivo. Cancer Research. 68. 2868–2868. 1 indexed citations
9.
Huebener, Nicole, Stefan Fest, Anne Strandsby, et al.. (2008). A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity. Molecular Cancer Therapeutics. 7(7). 2241–2251. 33 indexed citations
10.
Lode, Holger N., Nicole Huebener, Anne Strandsby, & Gerhard Gaedicke. (2007). Nutrient mixture including vitamin C, L‐lysine, L‐proline, and epigallocatechin is ineffective against tumor growth and metastasis in a syngeneic neuroblastoma model. Pediatric Blood & Cancer. 50(2). 284–288. 5 indexed citations
11.
Zeng, Yan, Nicole Huebener, Stefan Fest, et al.. (2007). Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells. Cancer Research. 67(5). 2331–2338. 53 indexed citations
12.
Lode, Holger N., Stefan Fest, Nicole Huebener, et al.. (2006). Peptide mutation analysis results in potent GD2 mimotope peptides for DNA vaccination against neuroblastoma. Cancer Research. 66. 332–332. 1 indexed citations
13.
Zeng, Yan, Jikai Jiang, Nicole Huebener, et al.. (2005). Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2. Cancer Letters. 228(1-2). 187–193. 26 indexed citations
14.
Fest, Stefan, Nicole Huebener, Yan Zeng, et al.. (2004). GD2 Peptide Mimotope DNA Vaccines for Anti-Neuroblastoma Immunotherapy.. Blood. 104(11). 1350–1350. 1 indexed citations
15.
Lode, Holger N., Nicole Huebener, Yan Zeng, et al.. (2004). DNA Minigene Vaccination for Adjuvant Neuroblastoma Therapy. Annals of the New York Academy of Sciences. 1028(1). 113–121. 11 indexed citations
16.
Shamis, Marina, Nicole Huebener, Ulrike Schröeder, et al.. (2003). Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase. Cancer Letters. 197(1-2). 219–224. 7 indexed citations
17.
Huebener, Nicole, Claudia Lemmel, Hans‐Georg Rammensee, et al.. (2003). Vaccination with minigenes encoding for novel ‘self’ antigens are effective in DNA-vaccination against neuroblastoma. Cancer Letters. 197(1-2). 211–217. 27 indexed citations
18.
Huebener, Nicole & Holger N. Lode. (2003). AACR Special Conference in cancer research: ubiquitination in normal and cancer cells. Expert Opinion on Biological Therapy. 3(1). 187–192. 1 indexed citations
19.
Schröeder, Ulrike, Nicole Huebener, Anne Strandsby, et al.. (2003). Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma. Cancer Letters. 197(1-2). 225–230. 8 indexed citations
20.
Schröeder, Ulrike, Kathrin M. Bernt, Doron Shabat, et al.. (2003). Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia. Blood. 102(1). 246–253. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nourredine Himoudi Breakdown of academic impact, for papers by Cristina Mastini Breakdown of academic impact, for papers by Silke Landmeier Breakdown of academic impact, for papers by Lisa P. Seung Breakdown of academic impact, for papers by Qun Tao Breakdown of academic impact, for papers by Bipulendu Jena Breakdown of academic impact, for papers by Alberto Comes Breakdown of academic impact, for papers by Julien Fleurence Breakdown of academic impact, for papers by R. Masood Breakdown of academic impact, for papers by Larry D. Greenfield
Rankless by CCL
2026